≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Median Ca intake No. of Cases (Event) * N (Person- yr) Mean Follow-up, mo Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI P between groups *** P for trend ****
18635855 Umesawa 2008 Total stroke Ca intake Quintile 1 233 314 ~8305 (112,018) 13 y Adjusted (“multivariable+HTN) HR 1.00 -- -- .02
Quintile 2 344 257 ~8305 (106,354) 0.94 0.79, 1.13 NS
Quintile 3 439 252 ~8305 (106,435) 0.79 0.65, 0.97 <0.05
Quintile 4 603 247 ~8305 (104,697) 0.78 0.63, 0.96 <0.05
Quintile 5 753 251 ~8305 (104,186) 0.71 0.56, 0.89 <0.05
18635855 Umesawa 2008 CHD Ca intake Quintile 1 233 72 ~8305 (112,018) Adjusted (“multivariable+HTN) HR 1.00 -- -- NS
Quintile 2 344 72 ~8305 (106,354) 1.18 0.83, 1.68 NS
Quintile 3 439 56 ~8305 (106,435) 0.91 0.60, 1.37 NS
Quintile 4 603 58 ~8305 (104,697) 1.08 0.71, 1.65 NS
Quintile 5 753 64 ~8305 (104,186) 0.93 0.58, 1.50 NS

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

Number of subjects with outcome

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: R-Z

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.